Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210362963> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W4210362963 abstract "The nomenclature high-grade non-Hodgkin's lymphoma was repurposed in the World Health Organization (WHO) 2016 update as high-grade B cell lymphoma (HGBL). However, among the HGBL entities HGBL, not otherwise specified (NOS) remains a poorly described entity with a lack of literature regarding its treatment and prognosis. The baseline characteristics, treatment, and outcome of HGBL, NOS cases were analyzed. Thirty HGBL, NOS patients were diagnosed between January 2017 and December 2019. Their median age was 49.3 years, and 30% had advanced IPI. The majority received R-CHOP chemotherapy, while five patients received dose-adjusted R-EPOCH. At a median follow-up of 15 months, nine patients had disease progression or relapse. EFS and OS were 22 months (12.1–31.9 months) and 37 months (29.4–44.0 months) respectively. Only NCCN-IPI ≤ 2 showed significant influence on the outcome. The results were similar to the outcomes previously reported. This study highlights the importance of NCCN-IPI in ascertaining the prognosis of HGBL, NOS. The literature review suggests that more intensive chemotherapy is ideal for HGBL, NOS. However, prospective trials are needed to prove whether the treatment of HGBL, NOS can be tailored based on NCCN-IPI." @default.
- W4210362963 created "2022-02-08" @default.
- W4210362963 creator A5002149046 @default.
- W4210362963 creator A5005584060 @default.
- W4210362963 creator A5011376320 @default.
- W4210362963 creator A5019922265 @default.
- W4210362963 creator A5032436397 @default.
- W4210362963 creator A5039441410 @default.
- W4210362963 creator A5059799734 @default.
- W4210362963 creator A5061727601 @default.
- W4210362963 creator A5063710630 @default.
- W4210362963 creator A5069820541 @default.
- W4210362963 creator A5077018089 @default.
- W4210362963 date "2022-02-02" @default.
- W4210362963 modified "2023-10-18" @default.
- W4210362963 title "Therapeutic Outcomes in High-Grade B-Cell Lymphoma, NOS: Retrospective Analysis" @default.
- W4210362963 cites W2058015212 @default.
- W4210362963 cites W2082870448 @default.
- W4210362963 cites W2085276059 @default.
- W4210362963 cites W2119147717 @default.
- W4210362963 cites W2133869962 @default.
- W4210362963 cites W2155499847 @default.
- W4210362963 cites W2310716991 @default.
- W4210362963 cites W2497269089 @default.
- W4210362963 cites W2598700764 @default.
- W4210362963 cites W2625890245 @default.
- W4210362963 cites W2909711051 @default.
- W4210362963 cites W2913287241 @default.
- W4210362963 cites W2983250018 @default.
- W4210362963 cites W2983897734 @default.
- W4210362963 cites W3011262063 @default.
- W4210362963 doi "https://doi.org/10.1055/s-0041-1739365" @default.
- W4210362963 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35833044" @default.
- W4210362963 hasPublicationYear "2022" @default.
- W4210362963 type Work @default.
- W4210362963 citedByCount "0" @default.
- W4210362963 crossrefType "journal-article" @default.
- W4210362963 hasAuthorship W4210362963A5002149046 @default.
- W4210362963 hasAuthorship W4210362963A5005584060 @default.
- W4210362963 hasAuthorship W4210362963A5011376320 @default.
- W4210362963 hasAuthorship W4210362963A5019922265 @default.
- W4210362963 hasAuthorship W4210362963A5032436397 @default.
- W4210362963 hasAuthorship W4210362963A5039441410 @default.
- W4210362963 hasAuthorship W4210362963A5059799734 @default.
- W4210362963 hasAuthorship W4210362963A5061727601 @default.
- W4210362963 hasAuthorship W4210362963A5063710630 @default.
- W4210362963 hasAuthorship W4210362963A5069820541 @default.
- W4210362963 hasAuthorship W4210362963A5077018089 @default.
- W4210362963 hasBestOaLocation W42103629631 @default.
- W4210362963 hasConcept C126322002 @default.
- W4210362963 hasConcept C167135981 @default.
- W4210362963 hasConcept C187212893 @default.
- W4210362963 hasConcept C2776694085 @default.
- W4210362963 hasConcept C2779134260 @default.
- W4210362963 hasConcept C2779338263 @default.
- W4210362963 hasConcept C2779725641 @default.
- W4210362963 hasConcept C38180746 @default.
- W4210362963 hasConcept C71924100 @default.
- W4210362963 hasConceptScore W4210362963C126322002 @default.
- W4210362963 hasConceptScore W4210362963C167135981 @default.
- W4210362963 hasConceptScore W4210362963C187212893 @default.
- W4210362963 hasConceptScore W4210362963C2776694085 @default.
- W4210362963 hasConceptScore W4210362963C2779134260 @default.
- W4210362963 hasConceptScore W4210362963C2779338263 @default.
- W4210362963 hasConceptScore W4210362963C2779725641 @default.
- W4210362963 hasConceptScore W4210362963C38180746 @default.
- W4210362963 hasConceptScore W4210362963C71924100 @default.
- W4210362963 hasLocation W42103629631 @default.
- W4210362963 hasLocation W42103629632 @default.
- W4210362963 hasLocation W42103629633 @default.
- W4210362963 hasLocation W42103629634 @default.
- W4210362963 hasOpenAccess W4210362963 @default.
- W4210362963 hasPrimaryLocation W42103629631 @default.
- W4210362963 hasRelatedWork W2045177263 @default.
- W4210362963 hasRelatedWork W2105151527 @default.
- W4210362963 hasRelatedWork W2110443444 @default.
- W4210362963 hasRelatedWork W2341761393 @default.
- W4210362963 hasRelatedWork W2374533761 @default.
- W4210362963 hasRelatedWork W3009852707 @default.
- W4210362963 hasRelatedWork W3095141535 @default.
- W4210362963 hasRelatedWork W3208090289 @default.
- W4210362963 hasRelatedWork W3210359220 @default.
- W4210362963 hasRelatedWork W4255376461 @default.
- W4210362963 isParatext "false" @default.
- W4210362963 isRetracted "false" @default.
- W4210362963 workType "article" @default.